Syndromic Multiplex Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066553
  • May 2021
  • Medical Devices
  • 126 Pages
The global Syndromic Multiplex Diagnostic market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Syndromic Multiplex Diagnostic market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Syndromic Multiplex Diagnostic market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Syndromic Multiplex Diagnostic market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories, Akonni Biosystems, Inc., Applied BioCode, Inc, BioFire Diagnostics, GenePOC Inc, GenMark Diagnostics, Janssen Global Services, LLC,(Johnson & Johnson), Luminex Corporation, Mesa Biotech, Qiagen
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Syndromic Multiplex Diagnostic market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Syndromic Multiplex Diagnostic market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Syndromic Multiplex Diagnostic market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Syndromic Multiplex Diagnostic market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Syndromic Multiplex Diagnostic Market:
The Syndromic Multiplex Diagnostic market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories, Akonni Biosystems, Inc., Applied BioCode, Inc, BioFire Diagnostics, GenePOC Inc, GenMark Diagnostics, Janssen Global Services, LLC,(Johnson & Johnson), Luminex Corporation, Mesa Biotech, Qiagen

Syndromic Multiplex Diagnostic Market Segment Analysis:
By Syndromes
Gastrointestinal
Central Nervous System
Bloodstream
Pneumonia
Respiratory
End User
Hospitals
Diagnostics Laboratories
Research Institutes
Others

Geographic Coverage for Syndromic Multiplex Diagnostic Market:
The market research report on global Syndromic Multiplex Diagnostic market offers complete analysis across various regions across the world. The Syndromic Multiplex Diagnostic market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Syndromic Multiplex Diagnostic market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Syndromic Multiplex Diagnostic Market Value and Forecast
  • US
  • Canada
Europe Syndromic Multiplex Diagnostic Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Syndromic Multiplex Diagnostic Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Syndromic Multiplex Diagnostic Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Syndromic Multiplex Diagnostic Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Syndromic Multiplex Diagnostic market report:
  • The report provides key trends of the global Syndromic Multiplex Diagnostic market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Syndromic Multiplex Diagnostic industry
  • The report covers all the recent developments of the Syndromic Multiplex Diagnostic market and helps to provide current industry updates
  • The report covers a detailed look over the global Syndromic Multiplex Diagnostic Industry and provides with significant actionable insights
  • The Syndromic Multiplex Diagnostic market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Syndromic Multiplex Diagnostic market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Syndromic Multiplex Diagnostic market
  • Comprehensive analysis of the Syndromic Multiplex Diagnostic market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Syndromic Multiplex Diagnostic market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Syndromic Multiplex Diagnostic market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Syndromic Multiplex Diagnostic market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Syndromic Multiplex Diagnostic market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Syndromic Multiplex Diagnostic market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories
  • Akonni Biosystems, Inc.
  • Applied BioCode, Inc
  • BioFire Diagnostics
  • GenePOC Inc
  • GenMark Diagnostics
  • Janssen Global Services, LLC,(Johnson & Johnson)
  • Luminex Corporation
  • Mesa Biotech
  • Qiagen
  • Gastrointestinal
  • Central Nervous System
  • Bloodstream
  • Pneumonia
  • Respiratory
  • Hospitals
  • Diagnostics Laboratories
  • Research Institutes
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Syndromic Multiplex Diagnostic Market Snapshot
          2.1.1. Global Syndromic Multiplex Diagnostic Market By Syndromes,2019
               2.1.1.1.Gastrointestinal
               2.1.1.2.Central Nervous System
               2.1.1.3.Bloodstream
               2.1.1.4.Pneumonia
               2.1.1.5.Respiratory
          2.1.2. Global Syndromic Multiplex Diagnostic Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Diagnostics Laboratories
               2.1.2.3.Research Institutes
               2.1.2.4.Others
          2.1.3. Global Syndromic Multiplex Diagnostic Market By End-use,2019
          2.1.4. Global Syndromic Multiplex Diagnostic Market By Geography,2019

3. Global Syndromic Multiplex Diagnostic Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Syndromes, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Syndromes, 2020
     4.2. Global Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028

5. Global Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028

6. Global Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028

7. Global Syndromic Multiplex Diagnostic Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Syndromic Multiplex Diagnostic Market Analysis, 2018 – 2028 
          7.2.1. North America Syndromic Multiplex Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028
          7.2.3. North America Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Syndromic Multiplex Diagnostic Market Analysis, 2018 – 2028 
          7.3.1.  Europe Syndromic Multiplex Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028
          7.3.3. Europe Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Syndromic Multiplex Diagnostic Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Syndromic Multiplex Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028
          7.4.3. Asia Pacific Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Syndromic Multiplex Diagnostic Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Syndromic Multiplex Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028
          7.5.3. Latin America Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Syndromic Multiplex Diagnostic Market Analysis, 2018 – 2028 
          7.6.1.  MEA Syndromic Multiplex Diagnostic Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Syndromic Multiplex Diagnostic Market Size (US$), By Syndromes, 2018 – 2028
          7.6.3. MEA Syndromic Multiplex Diagnostic Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Syndromic Multiplex Diagnostic Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Syndromic Multiplex Diagnostic Providers
        8.4.1 Abbott Laboratories
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Geographic Operations
                8.4.1.3 Abbott Laboratories Financial Information
                8.4.1.4 Abbott Laboratories Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Key Developments
        8.4.2 Akonni Biosystems, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Akonni Biosystems, Inc. Geographic Operations
                8.4.2.3 Akonni Biosystems, Inc. Financial Information
                8.4.2.4 Akonni Biosystems, Inc. Product Positions/Portfolio
                8.4.2.5 Akonni Biosystems, Inc. Key Developments
        8.4.3 Applied BioCode, Inc
                8.4.3.1 Business Description
                8.4.3.2 Applied BioCode, Inc Geographic Operations
                8.4.3.3 Applied BioCode, Inc Financial Information
                8.4.3.4 Applied BioCode, Inc Product Positions/Portfolio
                8.4.3.5 Applied BioCode, Inc Key Developments
        8.4.4 BioFire Diagnostics
                8.4.4.1 Business Description
                8.4.4.2 BioFire Diagnostics Geographic Operations
                8.4.4.3 BioFire Diagnostics Financial Information
                8.4.4.4 BioFire Diagnostics Product Positions/Portfolio
                8.4.4.5 BioFire Diagnostics Key Developments
        8.4.5 GenePOC Inc
                8.4.5.1 Business Description
                8.4.5.2 GenePOC Inc Geographic Operations
                8.4.5.3 GenePOC Inc Financial Information
                8.4.5.4 GenePOC Inc Product Positions/Portfolio
                8.4.5.5 GenePOC Inc Key Developments
        8.4.6 GenMark Diagnostics
                8.4.6.1 Business Description
                8.4.6.2 GenMark Diagnostics Geographic Operations
                8.4.6.3 GenMark Diagnostics Financial Information
                8.4.6.4 GenMark Diagnostics Product Positions/Portfolio
                8.4.6.5 GenMark Diagnostics Key Developments
        8.4.7 Janssen Global Services, LLC,(Johnson & Johnson)
                8.4.7.1 Business Description
                8.4.7.2 Janssen Global Services, LLC,(Johnson & Johnson) Geographic Operations
                8.4.7.3 Janssen Global Services, LLC,(Johnson & Johnson) Financial Information
                8.4.7.4 Janssen Global Services, LLC,(Johnson & Johnson) Product Positions/Portfolio
                8.4.7.5 Janssen Global Services, LLC,(Johnson & Johnson) Key Developments
        8.4.8 Luminex Corporation
                8.4.8.1 Business Description
                8.4.8.2 Luminex Corporation Geographic Operations
                8.4.8.3 Luminex Corporation Financial Information
                8.4.8.4 Luminex Corporation Product Positions/Portfolio
                8.4.8.5 Luminex Corporation Key Developments
        8.4.9 Mesa Biotech
                8.4.9.1 Business Description
                8.4.9.2 Mesa Biotech Geographic Operations
                8.4.9.3 Mesa Biotech Financial Information
                8.4.9.4 Mesa Biotech Product Positions/Portfolio
                8.4.9.5 Mesa Biotech Key Developments
        8.4.10 Qiagen
                8.4.10.1 Business Description
                8.4.10.2 Qiagen Geographic Operations
                8.4.10.3 Qiagen Financial Information
                8.4.10.4 Qiagen Product Positions/Portfolio
                8.4.10.5 Qiagen Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Syndromic Multiplex Diagnostic Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Syndromic Multiplex Diagnostic Market Revenue, By Syndromes, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Syndromic Multiplex Diagnostic Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Syndromic Multiplex Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Syndromic Multiplex Diagnostic Market Revenue, By Syndromes, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Syndromic Multiplex Diagnostic Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Syndromic Multiplex Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Syndromic Multiplex Diagnostic Market Revenue, By Syndromes, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Syndromic Multiplex Diagnostic Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Syndromic Multiplex Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Syndromic Multiplex Diagnostic Market Revenue, By Syndromes, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Syndromic Multiplex Diagnostic Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Syndromic Multiplex Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Syndromic Multiplex Diagnostic Market Revenue, By Syndromes, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Syndromic Multiplex Diagnostic Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Syndromic Multiplex Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Syndromic Multiplex Diagnostic: Market Segmentation 
FIG. 2 Global Syndromic Multiplex Diagnostic Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Syndromic Multiplex Diagnostic Market, By Syndromes, 2019 (US$ Mn) 
FIG. 5 Global Syndromic Multiplex Diagnostic Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Syndromic Multiplex Diagnostic Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Syndromic Multiplex Diagnostic Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Syndromic Multiplex Diagnostic Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Syndromic Multiplex Diagnostic Providers, 2019
FIG. 11 Global Syndromic Multiplex Diagnostic Market Revenue Contribution, By Syndromes, 2019 & 2028 (Value %) 
FIG. 12 Global Syndromic Multiplex Diagnostic Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Syndromic Multiplex Diagnostic Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Syndromic Multiplex Diagnostic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Syndromic Multiplex Diagnostic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Syndromic Multiplex Diagnostic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Syndromic Multiplex Diagnostic Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Syndromic Multiplex Diagnostic Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Syndromic Multiplex Diagnostic market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Syndromic Multiplex Diagnostic Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Syndromic Multiplex Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  North America Syndromic Multiplex Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  North America Syndromic Multiplex Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Europe Syndromic Multiplex Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  Europe Syndromic Multiplex Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  Europe Syndromic Multiplex Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Syndromic Multiplex Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Syndromic Multiplex Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Syndromic Multiplex Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Latin America Syndromic Multiplex Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Syndromic Multiplex Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Syndromic Multiplex Diagnostic Market Value, By Country, 2018 – 2028
TABLE  MEA Syndromic Multiplex Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  MEA Syndromic Multiplex Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  MEA Syndromic Multiplex Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Akonni Biosystems, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Applied BioCode, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioFire Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GenePOC Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GenMark Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Janssen Global Services, LLC,(Johnson & Johnson): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Luminex Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mesa Biotech: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Syndromic Multiplex Diagnostic Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Syndromic Multiplex Diagnostic Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Syndromic Multiplex Diagnostic Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Syndromic Multiplex Diagnostic Market, By Geography, 2019 (US$ Mn)
FIG.  Global Syndromic Multiplex Diagnostic Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Syndromic Multiplex Diagnostic Providers, 2016
FIG.  Global Syndromic Multiplex Diagnostic Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Central Nervous System Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Bloodstream Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pneumonia Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Respiratory Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Syndromic Multiplex Diagnostic Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Diagnostics Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Research Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Syndromic Multiplex Diagnostic Market Value, 2018 – 2028, (US$ Mn)